Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Oxygen, oxidative stress, hypoxia, and heart failure
Frank J. Giordano
Frank J. Giordano
Published March 1, 2005
Citation Information: J Clin Invest. 2005;115(3):500-508. https://doi.org/10.1172/JCI24408.
View: Text | PDF
Review Series

Oxygen, oxidative stress, hypoxia, and heart failure

  • Text
  • PDF
Abstract

A constant supply of oxygen is indispensable for cardiac viability and function. However, the role of oxygen and oxygen-associated processes in the heart is complex, and they and can be either beneficial or contribute to cardiac dysfunction and death. As oxygen is a major determinant of cardiac gene expression, and a critical participant in the formation of ROS and numerous other cellular processes, consideration of its role in the heart is essential in understanding the pathogenesis of cardiac dysfunction.

Authors

Frank J. Giordano

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Role of oxygen in myocardial metabolism. (A) Schematic depiction of the ...
Role of oxygen in myocardial metabolism. (A) Schematic depiction of the pathways by which cardiac muscle utilizes various fuels, including fatty acids, glucose, lactate, and ketones. Glycolysis occurs in the cytosol and does not require oxygen. β-Oxidation of fatty acids, ketone metabolism, and the metabolism of glucose-derived intermediates all generate reduced flavoproteins (NADH2 and FADH2). (B) Schematic depiction of the process of oxidative phosphorylation in the mitochondria. Complexes 1_4 refer to specific electron transfer steps that occur in the mitochondria. A series of electron transfers among the flavoproteins (FMNH2, NADH2, FADH2), iron-sulfur, coenzyme Q, and the cytochromes a_c1, results in accumulation of protons in the space between the inner and outer mitochondrial membranes. This proton gradient provides the energy for ATP production via complex 5. Sustaining this crucial process requires the continuous availability of oxygen as the terminal electron acceptor in the chain. Fe2+S, reduced iron-sulfur; Fe3+S, oxidized iron-sulfur; FMN, flavin mononucleotide; cyt, cytochrome; CoQ, coenzyme Q.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts